Back

Effects of adding high- vs low-intensity resistance training to endurance training in patients with heart failure: Preliminary results of a randomized controlled trial

26 August 2022 (09:20 - 09:30)
Organised by:
Congress Presentation Part of: New challenges and strategies in cardiac rehabilitation Cardiovascular Rehabilitation ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Tin Gojevic

Hasselt University, Hasselt (Belgium)

5 More presentations in this session

Presentation thumbnail
Trends and outcomes of early rehabilitation in intensive care unit for patients with cardiovascular disease - A cohort study with propensity score-matched analysis
Doctor N. Hamazaki (Sagamihara, JP)
Abstract Slides Video
Presentation thumbnail
Cardiovascular rehabilitation delivery and outcomes in Switzerland: data from a national database over the last decade.
Doctor E. Tessitore (Geneva, CH)
Abstract Slides Video
Presentation thumbnail
Impact of small-airway disease on exercise intolerance and long-term outcomes in patients with heart failure and reduced or preserved ejection fraction
Mr D. Nagumo (Sagamihara, JP)
Abstract Slides Video
Presentation thumbnail
Associations between training characteristics and change in peak oxygen consumption following exercise training in patients with heart failure with preserved ejection fraction
Mr S. Mueller Stegner (Munich, DE)
Abstract Slides Video
Presentation thumbnail
An innovative cardiac rehabilitation based on the power-force-velocity profile to further improve cardiorespiratory capacities in coronary artery disease patients
Mrs M. Fanget (Saint-Etienne, FR)
Abstract Slides Video

Access the full session

Session thumbnail
New challenges and strategies in cardiac rehabilitation

The Event

Event poster

ESC Congress 2022

26 August 2022 09:20 CET
You may be interested in
thumbnail
Congress Session
Mobility and heart failure: what to recommend?
thumbnail
Congress Session
How to provide a personalised exercise prescription for a patient with heart failure
thumbnail
Congress Presentation
What is the optimal dosing of exercise intensity in HFpEF and HFrEF?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources